Fig. 3

Incidence of MACE in the SH group and control group in the low- to moderate-risk and high to very high-risk MRS group, respectively. The time-to-event analysis was conducted using the Kaplan–Meier method among 2 groups. P < 0.05 was considered significant (2-sided). MACE, major adverse cardiac events; MRS, Mehran risk score